INNATE PHARMA (EPA:IPH) Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces today its financial results for the first half of 2011
Transparency directive : regulatory news
31/08/2011 18:03
INNATE PHARMA's latest news
05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00
26/04/2023 22:50
21/04/2023 07:00
Other stories
16/05/2024 10:31
16/05/2024 12:49
16/05/2024 09:43
16/05/2024 14:43
16/05/2024 14:19
16/05/2024 14:22
16/05/2024 10:03
16/05/2024 12:06
16/05/2024 11:56
16/05/2024 13:04
16/05/2024 12:35
16/05/2024 10:47
16/05/2024 09:46
16/05/2024 11:30
16/05/2024 12:00
16/05/2024 14:26
16/05/2024 10:20
16/05/2024 01:03
16/05/2024 11:08
16/05/2024 09:56
15/05/2024 19:00
16/05/2024 11:17
16/05/2024 00:59
16/05/2024 00:56
16/05/2024 09:00
15/05/2024 22:30
16/05/2024 13:02
16/05/2024 12:32
16/05/2024 09:00
16/05/2024 10:23
16/05/2024 09:24
15/05/2024 22:40
15/05/2024 11:19
15/05/2024 15:00
16/05/2024 10:46
16/05/2024 14:43
16/05/2024 10:15
16/05/2024 13:45